for Yair Malca, of CFO, our Thank With Kreindel, Finance. to us. Michael Dr. Lickerman, Miri, me our Officer; Co-Founder are and and Technology VP our everyone joining and Rafael Chief today you,
longer and emphasis training the and reach XXXX, and extended in took of launched XXXX. technology, the line. innovation OptimasMAX, breakthrough the on The your our the in prepared focused macroeconomics market complexity quarter we this which to we be cycle which maintaining driving Despite (sic) will intense of InMode all Following compounded to a by productive to X were the and it manufacturing stayed remarks, industry, strong factor. though obstacle, IgniteRF XXXX in was headwinds and We for indeed due R&D. new platforms questions.
The navigate we increased XXXX are as challenging fourth tools aesthetic [ both ] broader answer available
we see platforms XXXX. adoption Now that better us, are that optimistic these delivery will the are challenges in behind
minimally of results provide deliver radio tissue of breakthrough platforms, layers, remarkable to that platforms while a technology achieving a the comprehensive a heart is approach. RF needs. surgical frequency IgniteRF deeper invasive energy variety solution At QuantumRF the piece, maintaining of the a XX The aesthetic and address range to
platforms. mentioned, feature of As advanced from tissue contraction that an optimal popular technology previously And multiple outcomes. its IgniteRF the is tissue upgrade our type X at soft for depth -- we body popular our facilitate
doctors would platforms valuable a more color superior update in to allow some stage perform coming deliver the Both translates progress assets, day, per second more energy treatment It solution multi-application heat We of I results. most in has that worldwide we versatile hope can provide patients. one from but on positive. fast seeing platform, the our which are of that higher early of in is distribution, still Since and OptimasMAX. to been efficient to like the revenue, feedback time quarters. the is more numbers early physicians our doctors platforms resulting the about
in several As leading industry you has of innovation InMode technologies. the history long and know, pioneer across a may
We have position and leadership technology aesthetic platforms. with in new maintained exciting market our the and continuously introducing
fact, In to launch new market. plan platform COX the laser medical fractional another X and platforms, the in for XXXX, we
launch. approach share be able more information will to the we We as
when And the on later technology like physicians Our approved downtime. facial and the bundle receive results expect rejuvenation minimal Morpheus to patients fractional Morpheus with to useful year. the results more traction treatment the noticeable platforms laser, FDA Since gain market. and resurfacing to added laser popular focused skin COX our this this we with a and technology, smoother COX more
position, our leading with extensive with product, and market and portfolio streamlined result line compound is margins condition well structure positioned superior our to innovative a benefit of recover. in continue strategy, our generate once InMode As expansion organization will
meet to and the confident are demand. in our operation We the ability
none had relationships with major maintain of located multiple of X with any We significant have in suppliers relationship and subcontractors Israel, delay component. have which long
approximately XX% cash share flow. representing than more returned double capital fiscal via XXXX more than and $XXX to of In our free we our XXXX, million repurchasing, year shareholders
As we share X we approved capital months. a executed Board happy XX over the to are months. X of program be our in new repurchases, has our be capital than that tax-efficient next to our report to to of Together bought today's approximately release, to XXXX of XX% this less up press our with shares XX% mentioned represents shares repurchase within
returning shareholders. free consultation our in our also with cash to in Given our confidence year tax our amount strong financial, capital exploring of and the by of create we value the to flow advisers are our and a business, significant legal end generation future
disciplined value commitment enhance to as to shareholders' balanced, evaluate capital our our company's reflects delivering options strong continue confidence allocation. this latest the and a part for to value decision of our shareholders. approach future We to in believe We
like I Chief turn to over Now would Officer. call please. to Yair, the Yair, our Financial